Draegerwerk AG & Co. KGaA
98.40
EUR
+0.80
(+0.82%)
ISIN
DE0005550636
Return %
Stock
S&P 500
1Y
28.96
14.20
3Y
98.89
81.12
5Y
40.17
68.34
Capital Structure
EUR
•
in mil. unless spec.Working Capital
EUR
•
in mil. unless spec.Growth Rates
EUR
•
in mil. unless spec.Quarterly Revenue
EUR
•
in mil. unless spec.Quarterly Earnings Per Share
EUR
•
in mil. unless spec.Quarterly Dividends Per Share
EUR
•
in mil. unless spec.Company Description
- CEO
- Stefan Dräger
- Full Time Employees
- 16,687
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Moislinger Allee 53-55 Luebeck SH Germany 23542
- IPO Date
- Jan 1, 1979
- Website
- draeger.com
- Similar Companies
- Business
- Drägerwerk AG & Co. KGaA develops, manufactures and markets medical and safety technology products and systems that protect, support and save lives in hospitals, fire departments, emergency services, mining and industrial settings. Founded in 1889 and headquartered in Lübeck, Germany, the family-controlled company operates through two main divisions; the medical division offers anaesthesia workstations, ventilators for intensive and emergency care, patient monitoring systems, neonatal incubators and thermoregulation equipment, phototherapy lights, surgical and examination lights, warming therapy devices, hospital consumables and accessories, medical gas pipeline systems, ceiling pendants and IT systems for operating theatres; the safety division provides respiratory protection equipment including self-contained breathing apparatus and powered air-purifying respirators, stationary and portable gas detection systems such as multi-gas detectors and flame detectors, professional diving technology, alcohol and drug testing devices, hazmat suits, head and eye protection, thermal imaging cameras, firefighting equipment, integrated hazard management solutions and fire training facilities. Dräger products serve acute point-of-care settings, perioperative care, resource extraction, chemical, oil and gas industries, fire and rescue services; the company sells in over 190 countries with sales and service subsidiaries in around 50 countries and maintains 18 to 20 development and production sites worldwide including in Germany, the United States, the United Kingdom, the Czech Republic, Sweden, South Africa and China. In recent developments, Dräger reported strong order intake and net sales growth in the first nine months of 2025 with expectations of 3.0 to 5.0 percent net sales increase for the full year, invested approximately EUR 333.1 million in research and development in 2024 while launching 24 new products, expanded infrastructure with a new warehouse in Lübeck to support its roughly 16,600 employees and over EUR 3.4 billion in 2024 net sales, and in October 2024 divested its measurement technology unit Dräger MSI GmbH to Rems Messtechnik GmbH & Co KG while ceasing safety technology operations in Russia amid geopolitical sanctions.
Company News
Contrasting Drägerwerk AG & Co. KGaA (OTCMKTS:DGWPF) and Butterfly Network (NYSE:BFLY)
Drägerwerk AG & Co. KGaA (DGWPF) Q2 2026 Earnings Call Transcript
Drägerwerk AG & Co. KGaA (DGWPF) Q4 2025 Earnings Call Transcript
Drägerwerk AG & Co. KGaA (DGWPF) Q3 2025 Earnings Call Transcript
Drägerwerk AG & Co. KGaA (DGWPF) Q2 2025 Earnings Call Transcript
Drägerwerk AG & Co KGaA (DGWPF) Q1 2025 Earnings Call Transcript